A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 134,250 shares of TEVA stock, worth $2.52 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
134,250
Previous 145,050 7.45%
Holding current value
$2.52 Million
Previous $2.05 Million 6.6%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $138,024 - $187,919
-10,800 Reduced 7.45%
134,250 $2.18 Million
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $29,342 - $39,682
-2,750 Reduced 1.86%
145,050 $2.05 Million
Q3 2023

Nov 08, 2023

SELL
$7.48 - $10.7 $4,488 - $6,420
-600 Reduced 0.4%
147,800 $1.51 Million
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $28,800 - $37,880
-4,000 Reduced 2.62%
148,400 $1.12 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $36,784 - $50,028
-4,400 Reduced 2.81%
152,400 $1.35 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $12,720 - $15,168
-1,600 Reduced 1.01%
156,800 $1.43 Million
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $120,050 - $209,125
-17,500 Reduced 9.95%
158,400 $1.28 Million
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $90,036 - $126,880
-12,200 Reduced 6.49%
175,900 $1.32 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $3,665 - $4,695
500 Added 0.27%
188,100 $1.77 Million
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $79,000 - $101,900
-10,000 Reduced 5.06%
187,600 $1.5 Million
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $289,080 - $337,552
29,200 Added 17.34%
197,600 $1.96 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $1.74 Million - $2.16 Million
168,400 New
168,400 $1.94 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.